Nasdaq 100 Falls 1.3% as AI-Linked Stocks Slide
The Nasdaq 100 fell 1.3%, or 400 points, to about 29,535 at midday Friday as CoreWeave dropped 9.3% amid lingering AI-infrastructure debt concerns. The S&P 500 slipped 0.3%, while the Dow rose 0.3%.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
9 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The Nasdaq 100 fell 1.3%, or 400 points, to about 29,535 at midday Friday as CoreWeave dropped 9.3% amid lingering AI-infrastructure debt concerns. The S&P 500 slipped 0.3%, while the Dow rose 0.3%.
() -- Pentair (PNR) reported preliminary Q2 results below market estimates and lowered its full-year outlook amid headwinds related to its pool segment. Pentair CFO Nick Brazis' unexpected departure, just four months after his appointment, adds near-term skepticism on the stock, RBC said in a note. RBC downgraded the s
() -- (Updates with index/price moves, macroeconomic/rates data, and company/geopolitical news from the first paragraph.) US equity indexes ground higher following a surprise decline in the wholesale price inflation rate and a signal from Iran that its allies could shut the maritime gateway to the Red Sea. The Nasdaq r
() -- IBM's (IBM) shares sank 25%, the steepest decline on the Dow and the S&P 500, after the tech giant issued Tuesday Q2 guidance below Wall Street expectations. More than 48.8 million shares of the company traded intraday compared with a daily average of about 9.11 million. Jet.AI (JTAI) has entered into a non-bindi
() -- Aimei Health Technology (AFJK) terminated its merger deal with United Hydrogen Group, effective immediately, as the companies failed to complete the transaction within the agreed timeframe, according to a statement Wednesday. Shares of Aimei sank 49% as intraday trading volume jumped to over 165,000 from a daily
() -- Chemomab Therapeutics (CMMB) and Scipher Medicine have entered into an all-stock merger agreement, the companies said Wednesday. Shares of Chemomab dropped 14% as intraday trading volume jumped to over 1.79 million from a daily average of about 75,000. Saratoga Investment (SAR) reported a decline in fiscal Q1 net
U.S. stocks fell for a second straight session on Wednesday as surging energy prices rekindled inflation fears and pushed Treasury yields higher, with equities sliding after President Donald Trump declared the June ceasefire with Iran “over.” The move followed a fresh U.S. strike on Iran and reports that Tehran had tar
() -- (Updates with index/price moves and company/political news) US equity indexes declined as chipmakers helped push technology lower, while a missile strike on a Qatari vessel sent crude oil higher. The Nasdaq Composite fell 0.6% to 25,972.1, the S&P 500 fell 0.2% to 7,519.8, and the Dow Jones Industrial Average ret
A deepening sell-off in chip and memory stocks dragged all four major U.S. equity indexes lower by midday Tuesday. Money rotated defensively, with health care, real estate and utilities the only sectors firmly higher, while industrials and technology lagged. The S&P 500 eased about 0.3% to 7,513, and the Dow Jones Indu